Malignant Prostate Neoplasm — Trials

Malignant Prostate Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

5,979 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,377
Recruiting: 744
Ph III recruiting: 79
Growth YoY: +22.4%
Industry share: 18%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 27.1%
Trials / 1,000 deaths: 40.6 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (730)

clinicaltrialsPublishedShowing 401–450 of 493 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05779943	Comparison of 18F-rhPSMA-7.3 PET/CT With and Without Furosemide in Biochemical Recurrence of Prostate Cancer	active not recruiting	Phase 2	20	Emory UniversityOTHER	1	Oct 27, 2025	clinicaltrials
NCT05540392	An Acupuncture Study for Prostate Cancer Survivors With Urinary Issues	active not recruiting	Phase 1 / Phase 2	60	Memorial Sloan Kettering Cancer CenterOTHER	1	Oct 10, 2025	clinicaltrials